Exploring novel vitrification agents and controlled-rate cooling matrices that preserve over 92% post-thaw metabolic enzyme viability for toxicological assays.
Primary human and rodent hepatocytes represent irreplaceable in vitro models for early preclinical drug metabolism and safety assessment. However, their sensitivity to freeze-thaw cycles historically challenged biobanking workflows.
Experimental Protocol Advances
By leveraging synthetic trehalose liposomes combined with stepped DMSO diminution, post-thaw cytochrome P450 (CYP3A4 and CYP2D6) induction capabilities remained equivalent to fresh tissue baselines.
This breakthrough enables distributed multi-center ADME profiling without time-sensitive donor procurement bottlenecks.